Воспаление жировой ткани (часть 7). Немедикаментозное лечение

В обзоре представлены экспериментальные и клинические данные об угнетении воспаления жировой ткани (ВЖТ) регулярной физической активностью и ограничением калорийности питания (ОКП). В ослаблении ВЖТ имеет значение уменьшение ожирения, стимуляция секреции глюкокортикоидов, улучшение толерантности к глюкозе, активация гормезиса. Обсуждены благоприятные эффекты миметиков ОКП: омега-3-жирных кислот, расвератрола, нарингенина, гесперидина, куркумина, а также средиземноморской диеты.

жировая ткань, воспаление, цитокины, средиземноморская диета, омега-3-жирные кислоты, расвератрол

1. Шварц В. Воспаление жировой ткани. Часть 6. Действие медикаментозных средств. Пробл эндокринол 2012; 1: 67-73.

2. Tisdale M.J. Biology of cachexia. J Natl Cancer Inst 1997; 89: 1763-1773.

3. Zhang X., Zhang G., Zhang H., Karin M., Bai H., Cai D. Hypothalamic IKK[beta]/NF-[kappa]B and ER Stress Link Overnutrition to Energy Imbalance and Obesity. Cell 2008; 135: 61-73.

4. Vendrell J., Broch M., Vilarassa N., Aylwin S.J., Batterham R.L., Borg C.M., Coyle F. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationship in obesity. Obes Res 2004; 12: 962-971.

5. Laimer M., Ebenbichler C.F., Kaser S., Sandhofer A., Weiss H., Nehoda H. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Dis 2002; 26: 659-662.

6. Klein S., Fontana L., Young V.L., Coggan A.R., Kilo C., Patterson B.W. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004; 350: 2549-2557.

7. Nicklas B.J., Ambrosius W., Messier S.P., Miller G.D. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr 2004; 79: 544-551.

8. Herder C., Peltonen M., Koenig W., Antikainen R.L., Kastarinen M.J., Jousilahti P. Antiinflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 2009; 52: 3: 423-430.

9. Esposito K., Pontillo A., Di Palo C., Giugliano G., Masella M., Marfella R., Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799-1804.

10. De Mello V.D., Kolehmainen M., Schwab U., Mager U., Laaksonen D.E., Pulkkinen L. Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome. Metabolism 2008; 57: 2: 192-199.

11. Rynders C., Weltman A., Delgiorno C., Balagopal P., Damaso L., Killen K., Mauras N. Lifestyle Intervention Improves Fitness Independent of Metformin in Obese Adolescents. Med Sci Sports Exerc 2011; 10: 235-247.

12. Simpson R.W., Shaw J.E., Zimmer P.Z. The prevention of type diabetes - lifestyle change or pharmacotherapy? A challenge for the 21st century. Diabetes Res Clin Pract 2003; 59: 3: 165-180.

13. Abramson J.L., Vaccarino V. Relationship between physikal activity and inflammation among apparently healthy middle-aged older US adults. Arch Intern Med 2002; 162: 1286-1292.

14. Fallon K.E., Fallon S.K., Boston T. The acute phase response and exercise: court and field sports. Br J Sports Med 2001; 35: 170-173.

15. Anton S.D., Manini T.M., Milsom V.A., Dubyak P., Cesari M., Cheng J. Effects of a weight loss plus exercise program on physical function in overweight, older women: a randomized controlled trial. Clin Int Aging 2011; 6: 141-149.

16. Tsukui S., Kanda T., Nara M., Tanko L.B., Bruun J.M., Alexandersen P. Moderate-intensity regular exercise decrease serum tumor necrose factor-alpha and HdF1c levels in healthy women. Int J Obes Relat Metab Dis 2000; 24: 1207-1211.

17. Ahmadi N., Eshaghian S., Huizenga R., Sosnin K., Ebrahimi R., Siegel R. Effects of intense exercise and moderate caloric restriction on cardiovascular risk factors and inflammation. Am J Med 2011; 124: 10: 978-982.

18. Petersen A.M., Pedersen B.K. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98: 4: 1154-1162.

19. Шварц В. Адипонектин: патофизиологические аспекты. Пат физиол и экспер тер 2009; 3: 34-38.

20. Simpson K.A., Singh M.A. Effects of exercise on adiponectin: a systematic review. Obesity: Silver Spring 2008; 16: 2: 241-256.

21. Teixeira de Lemos E., Reis F., Baptista S., Pinto R., Sepodes B., Vala H., Rocha-Pereira, da Silva G.C., Teixeira N., Silva A.S., Carvalho L., Teixeira F., Das U.N. Exercise training decreases proinflammatory profile in Zucker diabetic (type 2) fatty rats. Nutrition 2009; 25: 3: 330-339.

22. Kasapis C., Thompson P.D. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005; 45: 10: 1563-1569.

23. Fisman E.Z., Tenenbaum A. The ubiquitous interleukin-6: a time for Reappraisal. Cardiovasc Diabetol 2010; 9: 62-75.

24. Pedersen B.K. IL-6 signaling in exercise and disease. Biochem Soc Trans 2007; 35: 1295-1297.

25. Febbraio M.A., Hiscock N., Sacchetti M., Fischer C.P., Pedersen B.K. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 2004; 53: 1643-1648.

26. Penkowa M., Keller C., Keller P., Jauffred S., Pedersen B.K. Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. FASEB J 2003; 17: 2166-2168.

27. Ostrowski K., Rohde T., Asp S., Schjerling P., Pedersen B.K. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J. Physiol 1999; 515: Pt 1: 287-291.

28. Pedersen B.K., Febbraio M.A. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008; 88: 1379-1406.

29. Febbraio M.A., Steensberg A., Keller C., Starkie R.L., Nielsen H.B., Krustrup P. Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. J. Physiol 2003; 549: 607-612.

30. Шварц В. Двойственная роль интерлейкина-6 в развитии инсулинорезистентности. Пат физиол и экспер тер 2010; 1: 40-47.

31. Nishimura S., Manabe I., Nagasaki M., Hosoya Y., Yamashita H., Fujita Y. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest 2008; 118: 710-721.

32. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.

33. Halberg N., Wernstedt-Asterholm I., Scherer P.E. The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 2008; 37: 753-768.

34. Weigert C., Brodbeck K., Staiger H., Kausch C., Machicao F., Haring H.U., Schleicher E.D. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor kappa B. J Biol Chem 2004; 279: 23942-23952.

35. Gao Z., Zhang X., Zuberi A., Hwang D., Quon M.J., Lefevre M., Ye J. Inhibition of Insulin Sensitivity by Free Fatty Acids Requires Activation of Multiple Serine Kinases in 3T3-L1 Adipocytes. Mol Endocrinol 2004; 18: 2024-2034.

36. Costanzi S., Neumann S., Gershengorn M.C. Seven Transmembrane-spanning Receptors for Free Fatty Acids as Therapeutic Targets for Diabetes Mellitus: Pharmacological, Phylogenetic, and Drug Discovery Aspects. J Biol Chem 2008; 283: 16269-16273.

37. Nakamura T., Furuhashi M., Li P., Cao H., Tuncman G., Sonenberg N., Gorgun C.Z., Hotamisligil G.S. Double-Stranded RNA-Dependent Protein Kinase Links Pathogen Sensing with Stress and Metabolic Homeostasis. Cell 2010; 140: 338-348.

38. Hosogai N., Fukuhara A., Oshima K., Miyata Y., Tanaka S., Segawa K., Furukawa S., Tochino Y., Komuro R., Matsuda M., Shimomura I. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56: 901-911.

39. Halberg N., Khan T., Trujillo M.E., Wernstedt-Asterholm I., Attie A.D., Sherwani S., Wang Z.V., Landskroner-Eiger S., Dineen S., Magalang U.J., Brekken R.A., Scherer P.E. HIF 1 alpha Induces Fibrosis and Insulin Resistance in White Adipose Tissue. Mol Cell Biol 2009; 29: 4467-4483.

40. Ye J., Gao Z., Yin J., He H. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007; 293: E1118-E1128.

41. Шварц В. Жировая ткань как орган иммунной системы. Цитокины и воспаление 2009; 8: 4: 3-10.

42. Weiss E.P., Fontana L. Caloric restriction: powerful protection for the aging heart and vasculature. Am J Physiol Heart Circ Physiol 2011; 301: 4: H1205-H1219.

43. González O., Tobia C., Ebersole J., Novak M. Caloric restriction and chronic inflammatory diseases. Oral Dis 2011; 6: 429-438.

44. Higami Y., Pugh T.D., Page G.P., Allison D.B., Prolla T.A., Weindruch R. Adipose tissue energy metabolism: altered gene expression profile of mice subjected to long-term caloric restriction. FASEB J 2003; 17: 415-428.

45. Capel F., Klimčáková E., Viguerie N., Roussel., B., Vítková M., Kováčiková M., Polák J., Kováčová Z., Galitzky V., Langin D. Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization. Diabetes 2009; 58: 7: 1558-1567.

46. Ortega Martinez de Victoria E., Xu X., Koska J., Francisco A.M., Scalise M., Ferrante A.W., Krakoff J. Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy pima Indians. Diabetes 2009; 58: 2: 385-393.

47. Tsuchiya T., Higami Y., Komatsu T., Tanaka K., Honda S., Yamaza H., Chiba T., Ayabe H., Shimokawa I. Acute stress response in calorie-restricted rats to lipopolysaccharide-induced inflammation. Mech Ageing Dev 2005; 126: 568-579.

48. Clément K., Viguerie N., Poitou C., Carette C., Pelloux V., Curat C.A. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004; 18: 14: 1657-1669.

49. Viguerie N., Vidal H., Arner P., Holst C., Verdich C., Avizou S., Astrup A. Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia 2005; 48: 1: 123-131.

50. Kolehmainen M., Salopuro T., Schwab U.S., Kekäläinen J., Kallio P. Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. Int J Obes 2008; 32: 2: 292-303.

51. Fontana L., Villareal D.T., Weiss E.P., Racette S.B., Steger-May K., Klein S., Holloszy J.O. Calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial. Am J Physiol Endocrinol Metab 2007; 293: E197-E202.

52. Fontana L. Neuroendocrine Factors in the Regulation of Inflammation: Excessive Adiposity and Calorie Restriction. Experimental gerontology 2009; 44: 1-2: 41-45.

53. Sabatino F., Masoro E.J., Mcmahan C.A., Kuhn R.W. Assessment of the Role of the Glucocorticoid System in Aging Processes and in the Action of Food Restriction. Journals of Gerontology 1991; 46: B171-B179.

54. Han E.S., Evans T.R., Shu J.H., Lee S., Nelson J.F. Food restriction enhances endogenous and corticotropin-induced plasma elevations of free but not total corticosterone throughout life in rats. J Gerontol Series A-Biological. Sci Med Sci 2001; 56: B391-B397.

55. Nareika A., Im Y.B., Game B.A., Slate E.H., Sanders J.J., London S.D., Lopes-Virella M.F., Huang Y. High glucose markedly enhances lipopolysaccharide-induced CD14 expression in U937 histiocytes. Diabetes 2006; 55: A171-A184.

56. Nunn Alistair V., Guy Geoffrey E., Brodie James S., Bell Jimmy D. Inflammatory modulation of exercise salience: using hormesis to return to a healthy lifestyle. Nutr Metabol (London) 2010; 7: 87-97.

57. Willett W.C. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease. J Cardiovasc Med 2007; 8: Suppl 1: S42-S45.

58. Chakrabarti S.K., Cole B.K., Wen Y., Keller S.R., Nadler J.L. 12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes. Obesity 2009; 17: 9: 1657-1663.

59. Mente A., de Koning L., Shannon H.S., Anand S.S. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009; 169: 659-669.

60. Ishiyama J., Taguchi R., Akasaka Y., Shibata S., Ito M., Nagasawa M., Murakami K. Unsaturated FAs prevent palmitate-induced LOX-1 induction via inhibition of ER stress in macrophages. J Lipid Res 2011; 52: 2: 299-307.

61. Dandona P., Ghanim H., Chaudhuri A., Dhindsa S., Kim S.S. Macronutrient intake induces oxidative and inflammatory stress: potential relevance to atherosclerosis and insulin resistanc. Exp Mol Med 2010; 42: 4: 245-253.

62. Jenkins D.J., Josse A.R., Dorian P., Burr M.L., LaBelle Trangmar R., Kendall C.W., Cunnane S.C. Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricular arrhythmias. J Am Coll Nutr 2008; 27: 367-378.

63. Lee J.Y., Zhao L., Youn H.S., Weatherill A.R., Tapping R., Feng L., Lee W.H., Fitzgerald K.A., Hwang D.H. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 2004; 279: 16971-16979.

64. Perez-Martinez P., Perez-Jimenez F., Lopez-Miranda J. n-3 PUFA and lipotoxicity. Biochim Biophys Acta 2010; 1801: 3: 362-366.

65. Todoric J., Loffler M., Huber J., Weatherill A.R., Kenney R.D. Adipose tissue inflammation induced by high-fat diet in obese diabetic moce is prevented by n-3 polyunsaturated fatty acids. Diabetologia 2006; 112: 239-254.

66. Ghanim H., Mohanty P., Pathak R., Chaudhuri A., Sia C.L., Dandona P. Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care 2007; 30: 1406-1411.

67. Milne J.C., Lambert P.D., Schenk S., Smith J.J., Kenney R.D., Gagne D.J. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007; 450: 712-716.

68. Olholm J., Paulsen S.K., Cullberg K.B., Richelsen B., Pedersen S.B. Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int J Obes (Lond) 2010; 34: 1546-1553.

69. Englund Ogge L., Brohall G., Behre C.J., Schmidt C., Fagerberg B. Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-year-old Caucasian women: a population-based study with a focus on impaired glucose regulation. Diabetes Care 2006; 29: 908-913.

70. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009; 41: 40-59.